Page 420 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

394 Rami N. Al-Rohil and J. Andew Carlson

[4] Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am. J. Clin. Dermatol.
2008; 9:71-92.

[5] Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill
Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65:1-11.

[6] Ruperto N, Ozen S, Pistorio A, et al. EULAR/PINTO/PRES criteria for Henoch-
Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis
and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and
clinical characterization. Ann. Rheum Dis. 2010; 69:790-797.

[7] Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-
Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis
and childhood Takayasu arteritis. Ankara 2008. Part II: Final Classification. Ann.
Rheum Dis. 2010; 69:798-806.

[8] Lane SE, Watts R, Scott DG. Epidemiology of systemic vasculitis. Curr. Rheumatol.
Rep. 2005; 7:270- 275.

[9] Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus
erythematosus: Prevalence and clinical characteristics in 670 patients. Medicine 2006;
85:95-104.

[10] Tai YJ, Chong AH, Williams RA, et al. Retrospective analysis of adult patients with
cutaneous leukocytoclastic vasculitis. Australas J. Dermatol. 2006; 47:92-96.

[11] Sunderkötter C, Seeliger S, Schönlau F, et al. Different pathways leading to cutaneous
leukocytoclastic vasculitis in mice. Exp. Dermatol.2001; 10:391-404.

[12] Haas M, Kraus ES, Samaniego-Picota M, et al. Acute renal allograft rejection with
intimal arteritis: histologic predictors of response to therapy and graft survival. Kidney
Int. 2002; 61:1516-1526.

[13] Mihatsch MJ, Nickeleit V, Gudat F. Morphologic criteria of chronic renal allograft
rejection. Transplant. Proc. 1999; 31:1295-1297.

[14] Ioannidou DJ, Krasagakis K, Daphnis EK, et al. Cutaneous small vessel vasculitis: an
entity with frequent renal involvement. Arch. Dermatol. 2002; 138:412-414.

[15] Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and
management. Clin. Dermatol. 2006; 24:414-429.

[16] Sais G, Vidaller A, Jucgla A, et al. Prognostic factors in leukocytoclastic vasculitis: a
clinicopathologic study of 160 patients. Arch. Dermatol. 1998; 134:309-315.

[17] Chen KR, Toyohara A, Suzuki A, et al. Clinical and histopathological spectrum of
cutaneous vasculitis in rheumatoid arthritis. Br. J. Dermatol. 2002; 147:905-913.

[18] Carlson JA, Chen KR. Cutaneous vasculitis update: small vessel neutrophilic vasculitis
syndromes. Am. J. Dermatopathol. 2006; 28:486-506.

[19] Watts A, Scott DG, Jayne DR, et al. Renal vasculitis in Japan and the UK--are there
differences in epidemiology and clinical phenotype? Nephrol. Dial Transplant 2008;
23:3928-3931.

[20] Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: presentation,
pathology and prognosis. Q. J. Med. 1985; 56:467-483.

[21] Kawakami T, Soma Y, Saito C, et al. Cutaneous manifestations in patients with
microscopic polyangiitis: two case reports and a minireview. Acta Derm. Venereol.
2006; 86:144-147.

[22] Agard C, Mouthon L, Mahr A, et al. Microscopic polyangiitis and polyarteritis nodosa:
how and when do they start? Arthritis Rheum. 2003; 49:709-715.

Complimentary Contributor Copy